Zdrowie i gospodarka · 25/06/2001

FDA Announces Submission of Information Collection for OMB Review

The Food and Drug Administration (FDA) is requesting public comment on the proposed collection of information, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, in accordance with the Biomaterials Access Assurance Act of 1998.